StockData
Kamada Ltd logo

Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30
$7.83−0.24 (-2.97%)

Close on Nov 19, 2026Market cap $451.68MP/E –Yield –

Kamada gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Kamada's gross profit for the twelve months ending Jun 30, 2026 was $78.31M, up 5.9% year over year. For fiscal 2025 it was $76.41M, up 9.2% from the year before. Over ten years it grew 17.4% a year on average. The highest annual figure on record is $76.41M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$76.41M+9.2%
FY2024Dec 31, 2024$69.97M+26.1%
FY2023Dec 31, 2023$55.49M+18.8%
FY2022Dec 31, 2022$46.70M+54.0%
FY2021Dec 31, 2021$30.33M-36.2%
FY2020Dec 31, 2020$47.55M-4.4%
FY2019Dec 31, 2019$49.74M+19.9%
FY2018Dec 31, 2018$41.47M+29.2%
FY2017Dec 31, 2017$32.09M+50.2%
FY2016Dec 31, 2016$21.36M+39.0%
FY2015Dec 31, 2015$15.37M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.47M+18.7%
Q1 FY2026Mar 31, 2026$19.12M-7.9%
Q4 FY2025Dec 31, 2025$16.97M-0.4%
Q3 FY2025Sep 30, 2025$19.76M+14.7%
Q2 FY2025Jun 30, 2025$18.93M-0.1%
Q1 FY2025Mar 31, 2025$20.75M+23.9%
Q4 FY2024Dec 31, 2024$17.03M+18.2%
Q3 FY2024Sep 30, 2024$17.23M+16.4%
Q2 FY2024Jun 30, 2024$18.95M+31.3%
Q1 FY2024Mar 31, 2024$16.75M+141390.0%
Q4 FY2023Dec 31, 2023$14.41M-69.1%
Q3 FY2023Sep 30, 2023$14.80M+114919.4%
Q2 FY2023Jun 30, 2023$14.44M+99.4%
Q1 FY2023Mar 31, 2023$11.84K-99.9%
Q4 FY2022Dec 31, 2022$46.67M+607.7%
Q3 FY2022Sep 30, 2022$12.87K-99.8%
Q2 FY2022Jun 30, 2022$7.24M-20.2%
Q1 FY2022Mar 31, 2022$11.30M+11.2%
Q4 FY2021Dec 31, 2021$6.60M-55.5%
Q3 FY2021Sep 30, 2021$5.73M–
Q2 FY2021Jun 30, 2021$9.07M–
Q4 FY2020Dec 31, 2020$10.17M–
Q3 FY2020Sep 30, 2020$14.82M–

More Kamada figures

See a number that looks wrong?